SGLT2 Inhibitors in post myocardial infarction
City
Webinar
Type of event
virtual
Invitation
Dear Dr.
The Zurich Heart House would like to invite you to a special webinar on
SGLT2 Inhibitors in post myocardial infarction
Date: Thursday, November 28th, 2024, 17:00 – 18:30 CET
We are looking forward to meeting you during this webinar.
Thomas F. Lüscher, Zurich/London
Programme
Chair: Thomas F. Lüscher, London/Zurich
| 17:00 | Outcomes after acute coronary syndromes 2024 | Stefan Toggweiler, Luzern |
| 17:15 | Q&A | |
| 17:20 | The effects of cardiovascular rehabilitation on HF and post MI patients | Jan Vontobel, Davos |
| 17:35 | Q&A | |
| 17:40 | Effect of Empagliflozin on HF outcomes after acute MI | Adrian Hernandez, Durham |
| 17:55 | Q&A | |
| 18:00 | EMPACT-MI: Design and results | Stefan Anker, Berlin |
| 18:15 | Q&A | |
| 18:20 | Panel Discussion | |
| 18:30 | End of symposium |
The programme may be subject to change.
This programme is supported by Boehringer Ingelheim. The scientific programme has not been influenced in any way by its sponsor.
Accreditation
This webinar has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 1.5 European CME credits (ECMEC®s).
Organized by
Register here
